ATRA vs AMZN · rev $1.1M vs P/E 31, rev $716.92B
Atara Biotherapeutics Inc (ATRA) versus Amazon.com Inc (AMZN) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Amazon.com Inc (AMZN) is a internet retail company listed on NASDAQ. It is led by Andrew R. Jassy.
Latest reported ATRA revenue for 2026-06-30 was $1.1M. Net income was -$9.0M. ATRA currently screens at market cap $87.1M.
Latest reported AMZN revenue for 2025-12-31 was $716.92B. Net income was $77.67B. Revenue was up 12.4% from 2024-12-31 to 2025-12-31. AMZN currently screens at market cap $2.55T and trailing P/E 30.6.
ATRA currently screens at market cap $87.1M. AMZN currently screens at market cap $2.55T and trailing P/E 30.6.
Not investment advice. Open the ATRA and AMZN stock pages for the full models.
Not investment advice.